 Home > Active Ingredient News > Blood System > FDA approves PEPAXTO (melphalan flubenzamide) for the treatment of relapsed and refractory multiple myeloma

FDA approves PEPAXTO (melphalan flubenzamide) for the treatment of relapsed and refractory multiple myeloma

 Last Update: 2021-03-19
 Source: Internet
 Author: User

Tags

uses monoclonal antibodies

alkylating agents chemotherapy

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Oncopeptides biotechnology company, announced today that the US Food and Drug Administration Administration ( the FDA ) has approved PEPAXTO® (melphalan fluorobenzamide) and dexamethasone combination, for the treatment of relapsed or refractory multiple myeloma patients, These patients have previously received at least four previous therapies, including proteasome inhibitors, immunomodulators , and monoclonal antibodies that target CD38.

Manage FDA immunity

Oncopeptides will immediately begin to promote PEPAXTO to healthcare professionals across the United States.

PEPAXTO is an anti-cancer peptide-drug conjugate (PDC) that targets aminopeptidase and rapidly releases alkylating agents into tumor cells.

Original source:

https://target="_blank" rel="noopener">https:// style="vertical-align: inherit;"> https:// leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

SULODEXIDE 99% Almost White Powder Dideu-01112 Dideu

CAS No.: 57821-29-1

Pharmacy Grade

$61.76/G EXW

Heparin sodium 9041-08-1 vials safe delivery

CAS No.: 9041-08-1

Pharmacy Grade

$1/G EXW

Gadusol Powder Gadusol76663-30-4

CAS No.: 76663-30-4

Industrial Grade

$1-1.01/G FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.